ClinTrial Networks
ClinTrial Networks consists of a group of independently owned investigator sites located throughout the United States and Asia Pacific
Who We Are
ClinTrial Networks consists of a group of independently owned investigator sites located throughout the United States and Asia Pacific, however we are not an SMO. Sites complete their own CDA’s Feasibility Questionnaires and regulatory documents. Each site has extensive research experience and conduct studies across a broad range of therapeutic areas. Each site has dedicated research staff consisting of highly trained investigators and study coordinators, uses central IRBs with start-up regulatory document turnaround time within 5 days, and is in full compliance with FDA, GCP, ICH, and IRB guidelines.
What We Do
Independently owned sites which share the following criteria:
Multi-specialty site
Minimum of five study coordinators
Ability to use central IRB
Dedicated regulatory document specialists at each site
Start up regulatory documents completed within five days
Patient recruiters at each site
QA program in place at each site
Remote data entry capabilities
Emphasis on investigator and coordinator training.
Our Mission, Values & Vision
Our Commitments
Our Mission
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Our Values
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Our Vision
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Our Team
Meet Our Founder
Director
Brian Norton
Brian Norton has thrived in the clinical research industry for 15 years, ranging from Phase I to IV programs, in a wide range of therapeutic Indications. Over the course of the past 5 years, he founded and managed four successful clinical research sites, where he also served as Director of Research Operations, Director of Patient Recruitment and Community Liaison as well as Director, Business Development. Brian leveraged both his business and extensive clinical experience by founding ClinTrial Networks in 2007. Brian currently serves as the Business Development Director for several dedicated trial sites nationwide and has created a solid network with Sponsors and CROs built on years of trust and respect. Brian holds his Bachelors of Science (Honors) in Hospital Administration from Southern Illinois University. He also holds certificates in several advanced courses including Advanced Clinical Drug Monitoring and GCP/ICH.